Journals / Dicle Tıp Dergisi / 2005 / Cilt: 32 - Sayı: 3

Evaluation of the efficacy and safety of oral ibuprofen in the treatment of patent ductus arteriosus

Preterm bebeklerde patent duktus arteriozus tedavisinde oral ibuprofenin etkinliğinin ve güvenirliliğinin değerlendirilmesi

Pages
140–144
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, treatment with oral ibuprofen is an effective and safe treatment method for the closure of the PDA in preterm infants.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since indomethacin has many side effects, ibuprofen has been started to be used with beneficial results and less side effects for the closure of patent ductus arteriosus (PDA) in recent years.
📊
Key Findings & Data:The frequency of PDA, and the effects and side effects of oral ibuprofen were investigated by echocardiographic evaluation, in 164 preterm neonates in Neonatology Unit of Dicle University, between April and December 2004.
💡
Conclusion & Impact:In conclusion, treatment with oral ibuprofen is an effective and safe treatment method for the closure of the PDA in preterm infants.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Duktus arteriyozus açıklığı · Ekokardiyografi · İbuprofen

Abstract

Since indomethacin has many side effects, ibuprofen has been started to be used with beneficial results and less side effects for the closure of patent ductus arteriosus (PDA) in recent years. The frequency of PDA, and the effects and side effects of oral ibuprofen were investigated by echocardiographic evaluation, in 164 preterm neonates in Neonatology Unit of Dicle University, between April and December 2004. Oral ibufrofen was given at 10 mg/kg/day dose to infants who had significant left-right shunt on the third day of birth but those who had contraindication for ibuprofen were excluded. By daily echocardiographic evaluations in those without closure after the first dose, a second and third dose of 5 mg/kg/day were given if necessary. Ductus closure has ocured in 24 of 27 (88.8%) patients, at a mean period of 1.7±0.9 (1-4) days. Complications like hyponatremia, hypercreatininemia, thrombocytopenia, and necrotizing enterocolitis were not seen. Only in one patient intracranial hemorrhage was occured two days after the treatment. In conclusion, treatment with oral ibuprofen is an effective and safe treatment method for the closure of the PDA in preterm infants.

Özet

Preterm yenidoğanlarda patent duktus arteriozusun (PDA) ilaçla kapatılmasında etkinliği kanıtlanmış olan indometasinin yan etkilerinin fazla olması nedeniyle, son yıllarda ibuprofen ile ilgili çalışmalar yapılmakta, sonuçlarının iyi, yan etkilerinin daha az olduğu bildirilmektedir. Dicle Üniversitesi Yenidoğan Servisi’ne Nisan-Aralık 2004 tarihleri arasında yatırılan 164 preterm yenidoğanda ekokardiyografik inceleme ile prospektif olarak PDA sıklığı ve önemli şantı olanlarda oral ibuprofenin kapanma üzerine etkinliği ve yan etkileri araştırıldı. Doğum sonrası üçüncü gününde duktusundan hala önemli sol-sağ şantı olan hastalardan kontrendikasyonu olmayanlara 10 mg/kg/gün dozda oral ibuprofen verildi. Günlük ekokardiyografi kontrollerinde ilk doz ile kapanma sağlanamayan hastalarda, 24 saat sonra 5 mg/kg/gün ikinci doz ve bununla da kapanmayanlarda 5 mg/kg/gün üçüncü doz verildi. İbuprofen verilen 27 hastanın 24’ünde (%88.8) duktus ortalama 1.7±0.9 (1-4) günde kapandı. İlaca bağlı, hiponatremi, hiperkreatininemi, trombositopeni, nekrotizan enterokolit gibi komplikasyonlar görülmezken bir hastada tedaviden iki gün sonra intrakraniyal kanama saptandı. Sonuç olarak, oral ibuprofen tedavisinin preterm yenidoğanlardaki PDA’ların ilaçla kapatılmasında güvenle kullanılabilecek etkili bir uygulama olduğu söylenebilir.

🔖

Cite This Article

KERVANCIOĞLU, M., DEVECİOĞLU, C., Köksal, O. (2005). Evaluation of the efficacy and safety of oral ibuprofen in the treatment of patent ductus arteriosus. Dicle Tıp Dergisi, Cilt: 32 - Sayı: 3, 140–144. https://ajindex.com/articles/349379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Cotton RB, Stahlman MT, Bender HW, Graham et al. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr, 1978; 93: 647-651
  2. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very low-birth-weight infants. N Engl J Med, 1982; 306: 506-510
  3. Akısü M, Özyürek AR, Dorak C, Parlar A, Kültürsay N. Prematüre bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazin. Çocuk Sağlığı ve Hastalıkları Dergisi, 2001; 44: 56-60
  4. Su PH, Chen JY, Su CM, et al. Comparison of ibufrofen and indometacin therapy for patent ductus arteriosus in preterm infants. Pediatr Intern, 2003; 45: 665-670
  5. Satar M, Narlı N, Özbarlas N, Atıcı A, Küçükosmanoğlu O. Yenidoğan bebeklerde patent duktus arteriozus ve indometazin tedavisinin değerlendirilmesi. Çocuk Sağlığı ve Hastalıkları Dergisi, 1998; 41: 327-333
  6. Gregoire N, Gualano V, Geneteau A, et al. Population pharmacokinetics of ibuprofen enantiomers in very premature neonates. J Clin Pharmacol, 2004; 44: 1114-1124
  7. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indometacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai, 2003; 86 Suppl 3: 563-569
  8. Heyman E, Morag I, Batash D, et al. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a plot study. Pediatrics, 2003; 112: 354-358
  9. Tekşam Ö, Yiğit Ş, Karagöz T, ve ark. Yenidoğan bebeklerde patent duktus arteriozusun tedavisinde oral ibuprofen ve intravenöz indometazin: bir retrospektif çalışma. Çocuk Sağlığı ve Hastalıkları Dergisi, 2004; 47: 96-102
  10. Barst RJ, Gersony WM. The pharmacological treatment of patent ductus arteriosus: a review of the evidence. Drugs, 1989; 38: 249-266
  11. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med, 1976; 295: 526-529
  12. Reller MD, Lorenz JM, Kotagal UR, Meyer RA, Kaplan S. Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol, 1985; 6: 17-23
  13. Gersony WM, Peckham GJ, Ellison CR, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative stu